These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21279620)
1. Detecting amyloid-β plaques in Alzheimer's disease. Baltes C; Princz-Kranz F; Rudin M; Mueggler T Methods Mol Biol; 2011; 711():511-33. PubMed ID: 21279620 [TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
3. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice. Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051 [TBL] [Abstract][Full Text] [Related]
4. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy. Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006 [TBL] [Abstract][Full Text] [Related]
5. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice. Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
7. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
8. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease. Thiessen JD; Glazner KA; Nafez S; Schellenberg AE; Buist R; Martin M; Albensi BC Brain Struct Funct; 2010 Jul; 215(1):29-36. PubMed ID: 20512361 [TBL] [Abstract][Full Text] [Related]
9. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI). Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135 [TBL] [Abstract][Full Text] [Related]
10. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749 [TBL] [Abstract][Full Text] [Related]
11. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease? Nichols L; Pike VW; Cai L; Innis RB Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944 [TBL] [Abstract][Full Text] [Related]
12. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease. Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice. Luo F; Seifert TR; Edalji R; Loebbert RW; Hradil VP; Harlan J; Schmidt M; Nimmrich V; Cox BF; Fox GB Neuroscience; 2008 Jul; 155(1):263-9. PubMed ID: 18534764 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201 [TBL] [Abstract][Full Text] [Related]
15. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains. Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738 [TBL] [Abstract][Full Text] [Related]
16. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829 [TBL] [Abstract][Full Text] [Related]
17. Amyloid imaging: from benchtop to bedside. Wu C; Pike VW; Wang Y Curr Top Dev Biol; 2005; 70():171-213. PubMed ID: 16338342 [TBL] [Abstract][Full Text] [Related]
19. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
20. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Wang L; Sato H; Zhao S; Tooyama I Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]